|
B3GALTL expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.456990E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.984200E-01 |
| Normal-vs-Stage2 |
5.463500E-02 |
| Normal-vs-Stage3 |
5.502500E-02 |
| Normal-vs-Stage4 |
5.589000E-01 |
| Stage1-vs-Stage2 |
1.500760E-01 |
| Stage1-vs-Stage3 |
1.490770E-01 |
| Stage1-vs-Stage4 |
6.266600E-01 |
| Stage2-vs-Stage3 |
7.035200E-01 |
| Stage2-vs-Stage4 |
1.294420E-01 |
| Stage3-vs-Stage4 |
1.372830E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.019700E-02 |
| Normal-vs-AfricanAmerican |
2.961800E-01 |
| Normal-vs-Asian |
1.647180E-01 |
| Caucasian-vs-AfricanAmerican |
2.371000E-04 |
| Caucasian-vs-Asian |
2.605000E-04 |
| AfricanAmerican-vs-Asian |
8.847400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.117800E-01 |
| Normal-vs-Female |
1.304370E-01 |
| Male-vs-Female |
6.304400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.199400E-01 |
| Normal-vs-Age(41-60Yrs) |
6.094300E-02 |
| Normal-vs-Age(61-80Yrs) |
2.398100E-02 |
| Normal-vs-Age(81-100Yrs) |
5.700200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.401930E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.052390E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.790200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.888000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.323040E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.704400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.258400E-01 |
| Classical-VS-Follicular |
1.092600E-01 |
| Classical-VS-Other |
3.061600E-01 |
| Classical-VS-Normal |
3.302400E-01 |
| Tall-VS-Follicular |
8.809400E-01 |
| Tall-VS-Other |
2.945600E-01 |
| Tall-VS-Normal |
1.077190E-01 |
| Follicular-VS-Other |
1.368580E-01 |
| Follicular-VS-Normal |
6.955700E-02 |
| Other-VS-Normal |
6.853200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.518100E-02 |
| Normal-vs-N1 |
4.502600E-01 |
| N0-vs-N1 |
1.630000E-01 |
|
|
